Abstract

The goal of this session is to compare the benefits and harms of treatment with quetiapine-extended release (ER) versus aripiprazole in children and adolescents with psychosis.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call